 |
Amily |
|
Emily |
|
Lily |
159-2642-3062
服务热线（工作日：9:00-17:30）
武汉168飞艇计划生物科技有限公司
热搜词：燕窝酸，不饱和脂肪酸，神经酰胺，花青素，黄酮，皂苷
Wuhan Chemstan Biotechnology Co., Ltd.
武汉168飞艇计划生物科技有限公司
-
在线咨询 -
官方邮箱 -
微信下单
-
回到顶部
代谢组学
科研服务
抗体/蛋白
地 址：武汉市东湖新技术开发区高新大道666号，武汉
国家生物产业基地B、C、D区研发楼C1栋
产品销售：15926423062
技术服务：18971263062
E - mail ：info@hylpnm.com
邮 编：430075
化合物单体
168飞艇计划生物（Chemstan）所有产品和服务仅用于科学研究，不为任何个人或者非科研性质的用途提供产品和服务。
Copyright @ 武汉168飞艇计划生物科技有限公司.All rights reserved
网站建设：中企动力武汉鄂ICP备27143755号-1
浏览量:
产品名称：
Research Grade Narsoplimab (纳索利单抗 )
NO.
013
货号：
CSD00525
中文名称
纳索利单抗
英文名词
Research Grade Narsoplimab
CAS号
2108782-45-0
产品货号：
CSD00525
货期：
现货
价格与订购：
2480.00
数量：
-
+
库存：
100
产品信息
如何订购
货号（Catalog No.）icon
CSD00525
通用名INNicon
Narsoplimab
纯度(Purity)icon
>95%
浓度( Concentration)icon
1mg/ml
Formulationicon
PBS buffer PH7.5
Sourceicon
CHO cells
内毒素(Endotoxin level)icon
Please contact with the lab for this information.
产品描述(Description)icon
Narsoplimab is a human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), the effector enzyme of the lectin pathway of the complement system. The lectin pathway is one of the principal pathways of complement and is activated primarily by tissue damage and microbial infection. Importantly, inhibition of MASP-2 does not appear to interfere with the classical complement pathway, a critical component of the acquired immune response to infection. This novel, proprietary drug is designed to prevent complement-mediated inflammation and endothelial damage while leaving intact the respective functions of the other pathways of innate immunity.
别名(Alternative names)icon
OMS721
靶点;物种(Specificity target name;species)icon
MASP2[Homo sapiens]
种类(Species)icon
Homo sapiens
受体鉴定(Receptor identification)icon
IgG4-lambda
CASicon
2108782-45-0
存储条件(Storage)icon
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Noteicon
For research use only .
上一篇
Research Grade Pembrolizumab ( 帕博利珠单抗 )
Research Grade Tocilizumab ( 托珠单抗 )
下一篇